These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 17950672

  • 1. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ, Salata J, Mendez J, Reddy H, Goodrich R.
    Transfus Apher Sci; 2007 Oct; 37(2):131-7. PubMed ID: 17950672
    [Abstract] [Full Text] [Related]

  • 2. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Cardo LJ, Rentas FJ, Ketchum L, Salata J, Harman R, Melvin W, Weina PJ, Mendez J, Reddy H, Goodrich R.
    Vox Sang; 2006 Feb; 90(2):85-91. PubMed ID: 16430665
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma.
    Tonnetti L, Proctor MC, Reddy HL, Goodrich RP, Leiby DA.
    Transfusion; 2010 May; 50(5):1019-27. PubMed ID: 20030791
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The efficacy of photochemical treatment with methylene blue and light for the reduction of Trypanosoma cruzi in infected plasma.
    Gironés N, Bueno JL, Carrión J, Fresno M, Castro E.
    Vox Sang; 2006 Nov; 91(4):285-91. PubMed ID: 17105603
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.
    Goodrich RP, Gilmour D, Hovenga N, Keil SD.
    Transfusion; 2009 Jun; 49(6):1205-16. PubMed ID: 19320867
    [Abstract] [Full Text] [Related]

  • 9. Protein quality in Mirasol pathogen reduction technology-treated, apheresis-derived fresh-frozen plasma.
    Smith J, Rock G.
    Transfusion; 2010 Apr; 50(4):926-31. PubMed ID: 20051060
    [Abstract] [Full Text] [Related]

  • 10. Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light.
    Keil SD, Kiser P, Sullivan JJ, Kong AS, Reddy HL, Avery A, Goodrich RP.
    Transfusion; 2013 Oct; 53(10):2278-86. PubMed ID: 23320495
    [Abstract] [Full Text] [Related]

  • 11. Effects of a new pathogen-reduction technology (Mirasol PRT) on functional aspects of platelet concentrates.
    Perez-Pujol S, Tonda R, Lozano M, Fuste B, Lopez-Vilchez I, Galan AM, Li J, Goodrich R, Escolar G.
    Transfusion; 2005 Jun; 45(6):911-9. PubMed ID: 15934989
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.
    Keil SD, Saakadze N, Bowen R, Newman JL, Karatela S, Gordy P, Marschner S, Roback J, Hillyer CD.
    Transfusion; 2015 Apr; 55(4):858-63. PubMed ID: 25438832
    [Abstract] [Full Text] [Related]

  • 14. Trypanosoma cruzi inactivation in human platelet concentrates and plasma by a psoralen (amotosalen HCl) and long-wavelength UV.
    Van Voorhis WC, Barrett LK, Eastman RT, Alfonso R, Dupuis K.
    Antimicrob Agents Chemother; 2003 Feb; 47(2):475-9. PubMed ID: 12543646
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at -30 degrees C.
    Bihm DJ, Ettinger A, Buytaert-Hoefen KA, Hendrix BK, Maldonado-Codina G, Rock G, Giclas PC, Goodrich RP.
    Vox Sang; 2010 Feb; 98(2):108-15. PubMed ID: 19719460
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Update on pathogen reduction technology for therapeutic plasma: an overview.
    Solheim BG, Seghatchian J.
    Transfus Apher Sci; 2006 Aug; 35(1):83-90. PubMed ID: 16934528
    [Abstract] [Full Text] [Related]

  • 19. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units.
    Picker SM, Steisel A, Gathof BS.
    Transfusion; 2008 Aug; 48(8):1685-92. PubMed ID: 18513255
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.